BAM
Byrne Asset Management’s Quest Diagnostics DGX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24M | Sell |
6,887
-15
| -0.2% | -$2.69K | 0.82% | 33 |
|
|
2025
Q1 | $1.17M | Buy |
6,902
+48
| +0.7% | +$8.12K | 0.86% | 35 |
|
|
2024
Q4 | $1.03M | Sell |
6,854
-25
| -0.4% | -$3.77K | 0.73% | 47 |
|
|
2024
Q3 | $1.07M | Sell |
6,879
-65
| -0.9% | -$10.1K | 0.73% | 46 |
|
|
2024
Q2 | $954K | Sell |
6,944
-162
| -2% | -$22.2K | 0.68% | 46 |
|
|
2024
Q1 | $946K | Buy |
7,106
+170
| +2% | +$22.6K | 0.66% | 51 |
|
|
2023
Q4 | $954K | Buy |
+6,936
| New | +$954K | 0.73% | 47 |
|
|
2023
Q3 | – | Sell |
-6,827
| Closed | -$960K | – | 50 |
|
|
2023
Q2 | $960K | Buy |
6,827
+175
| +3% | +$24.6K | 0.62% | 48 |
|
|
2023
Q1 | $941K | Buy |
6,652
+15
| +0.2% | +$2.12K | 0.67% | 48 |
|
|
2022
Q4 | $1.04M | Buy |
6,637
+25
| +0.4% | +$3.91K | 0.75% | 41 |
|
|
2022
Q3 | $811K | Buy |
6,612
+647
| +11% | +$79.4K | 0.63% | 58 |
|
|
2022
Q2 | $793K | Buy |
5,965
+565
| +10% | +$75.1K | 0.59% | 57 |
|
|
2022
Q1 | $739K | Buy |
5,400
+152
| +3% | +$20.8K | 0.46% | 69 |
|
|
2021
Q4 | $908K | Buy |
+5,248
| New | +$908K | 0.59% | 50 |
|